The International Society for Advancement of Cytometry meets for the congress for cytometry (CYTO)
The world’s top minds in the field of cell and immunotherapy gathered in Philadelphia, PA to share cutting-edge science and technology in the single cell analysis domain.
20 Jun 2022
Scientists and leaders in the field of cytometry convened in Philadelphia, Pennsylvania at the Philadelphia Convention Center for the first time in three years to present and share scientific discoveries and explore the latest developments in flow and image cytometry, advanced microscopy, data evaluation, fluorescent reagents and other topics related to cell detection, measurement, and analysis. For those unable to attend, an abbreviated virtual option was available.
Dr. Jonni Moore, President of ISAC and CYTO meeting chair, opened the conference by highlighting the increasing impact of cytometry and patient care. According to Dr. Moore, “The Covid-19 pandemic demanded quick and comprehensive analysis of the infection and responses to vaccinations that could only be provided by cytometric measurements. Today, cytometry is at the forefront of technologies directly impacting the lives of patients every day.”
The CYTO 2022 Keynote Speaker was Drew Weissman, M.D., Ph.D., The Roberts Family Professor of Vaccine Research at Penn Medicine and a world-renowned physician and researcher who, along with his longtime collaborator Dr. Katalin Karikó, invented the base mRNA technology used in both Pfizer-BioNTech and Moderna Covid-19 vaccines.
In 2021, the team of Dr. Weissman and Dr. Karikó were presented the Lasker Award, frequently referred to as the American Nobel, for their groundbreaking work in mRNA technology. Dr. Moore emphasized how cytometry has been a major enabler of Dr. Weissman’s studies underscoring the critical partnership of technology and basic science in the development of vaccines.
Other highlights of the meeting included the participation of multiple biotech companies that launched a series of advanced cell analysis systems that will push forward biomedical science, especially in the rapidly growing areas of cell and immune therapies and vaccine development.
Technology highlights included:
- BennuBio, Inc. presents its newly designed Velocyt instrument
- BD unveils world's first spectral cell sorter with high-speed imaging technology that sorts cells based on visual characteristics
